LI
CTSO icon

Leap Investments’s Cytosorbents Corp CTSO Stock Holding History

Leap Investments’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$193K Buy
19,500
+5,300
+37% +$48.7K 0.13% 304
2020
Q1 		$110K Buy
+14,200
New +$71.7K 0.16% 255

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Leap Investments's CTSO Position: Q2 2020 in Review

Leap Investments increased its Cytosorbents Corp (CTSO) stake by 37% in Q2 2020, buying an estimated $48.7K and bringing the position to 19,500 shares worth $193K. The position accounts for 0.13% of the portfolio, ranked #304.

Leap Investments first reported a position in CTSO in Q1 2020 and has held it in 2 quarters since. 91 funds tracked by Wall St. Rank hold CTSO as of Q2 2020.

  • Leap Investments held 19,500 shares of Cytosorbents Corp worth $193K as of Q2 2020.
  • Leap Investments bought 5,300 Cytosorbents Corp shares in Q2 2020, an estimated $48.7K.
  • Cytosorbents Corp made up 0.13% of Leap Investments's portfolio in Q2 2020, its #304 holding.
  • Leap Investments first reported a position in Cytosorbents Corp in Q1 2020 and has held it in 2 quarters since.
  • 91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.